Skip to main content

Table 3 Univariate analysis of potential factors associated with PFS and OS [Median (Q25, Q75)]

From: Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy

Variable

Total(n = 278)

PFS

χ2

P

OS

χ2

P

Gender

  

0.769

0.381

 

2.584

0.108

 Male

192(69.1%)

6.0(5.16,6.85)

  

25.0(22.25,27.75)

  

 Female

86(30.9%)

6.0(4.18,7.82)

  

26.00(20.88,31.12)

  

Age

  

0.899

0.343

 

1.881

0.170

 < 60

109(39.2%)

6.0(5.28,6.72)

  

26.0(22.96,29.05)

  

 ≥ 60

169(60.8%)

6.0(4.84,7.16)

  

23.0(19.26,26.74)

  

Smoking status

  

0.065

0.799

 

1.598

0.206

 Minimal/never

116(41.7%)

6.0(4.76,7.24)

  

25.0(20.25,29.75)

  

 Current/former

162(58.3%)

6.0(4.96,7.04)

  

25.0(22.16,27.84)

  

ECOG-PS

  

1.615

0.204

 

5.642

0.018

 0/1

160(57.6%)

6.0(4.97,7.03)

  

27.0(24.68,29.32)

  

 2

118(42.4%)

6.0(4.94,7.06)

  

22.0(19.76,24.24)

  

Histology subtype

  

0.646

0.724

 

1.730

0.421

 Squamous

113(40.6%)

6.0(4.85,7.15)

  

25.0(22.48,27.52)

  

 Adenocarcinoma

133(47.8%)

6.0(4.67,7.33)

  

25.0(20.72,29.28)

  

 others

32(11.5%)

6.0(4.63,7.38)

  

26.0(15.7,36.26)

  

TNM staging

  

6.549

0.010

 

12.981

0.000

 III

102(36.7%)

6.0(5.24,6.76)

  

27.0(23.35,30.65)

  

 IV

176(63.3%)

6.0(4.76,7.24)

  

23.0(20.23,25.77)

  

Chemotherapy regimens

  

1.156

0.885

 

1.419

0.841

 DP

32(11.5%)

5.0(1.67,8.33)

  

20.0(14.46,25.54)

  

 GP

97(34.9%)

6.0(4.79,7.21)

  

26.0(22.08,29.92)

  

 NP

37(13.3%)

7.0(4.02,9.98)

  

23.0(15.87,30.13)

  

 PC

83(29.9%)

6.0(5.01,6.99)

  

25.0(20.71,29.29)

  

 TP

29(10.4%)

5.0(3.49,6.51)

  

26.0(19.87,32.13)

  

CEA

  

3.240

0.072

 

2.163

0.141

 Normal

123(44.2%)

6.0(5.06,6.94)

  

25.0(22.02,27.98)

  

 High

155(55.8%)

6.0(4.54,7.46)

  

26.0(22.39,29.61)

  

CYF

  

3.147

0.076

 

1.105

0.293

 Normal

76(27.3%)

6.0(4.88,7.13)

  

25.0(21.92,28.08)

  

 High

202(72.7%)

6.0(4.97,7.03)

  

25.0(22.08,27.93)

  

NSE

  

0.945

0.331

 

1.406

0.236

 Normal

153(55.0%)

6.0(4.99,7.01)

  

23.0(20.49,25.51)

  

 High

125(45.0%)

6.0(4.71,7.29)

  

26.0(22.07,29.93)

  

SII

  

9.309

0.002

 

25.937

0.000

 < 984.72

140(50%)

7(5.45,8.54)

  

30.0(27.25,32.75)

  

 ≥ 984.72

138(50%)

5(4.26,5.74)

  

18.0(15.58,20.42)

  

PNI

  

13.631

0.000

 

48.178

0.000

 ≥ 48.95

129(46%)

7.0(5.81,8.19)

  

31.0(27.69,34.31)

  

 < 48.95

149(54%)

5.0(4.15,5.86)

  

18.0(15.51,20.49)

  

CONUT score

  

62.912

0.000

 

78.963

0.000

 < 3

164(59.0%)

8.0(5.72,10.28)

  

30.0(27.58,32.42)

  

 ≥ 3

114(41.1%)

4.0(3.13,4.87)

  

16.0(14.17,17.83)

  
  1. ECOG-PS  Eastern Cooperative Oncology Group performance status, TNM  Tumor-node-metastasis, CONUT  Controlling nutritional status, SII  Systemic immune-inflammation index, PNI  Prognostic nutritional index, DP  Docetaxel plus cisplatin, GP  Gemcitabine plus cisplatin, NP  Vinorelbine plus cisplatin, PC  Pemetrexed plus cisplatin, TP  Paclitaxel plus cisplatin, CEA  Carcinoembryonic antigen, NSE  Neuron-specific enolase, CYF  Cytokeratin-19-fragment